Eli Lilly Virus Antibody Trial Paused Due to Safety Concerns
- Date: 14-Oct-2020
- Source: Bloomberg
- Sector:Healthcare
- Country:Middle East
Eli Lilly Virus Antibody Trial Paused Due to Safety Concerns
Eli Lilly & Co. said enrollment of participants in a clinical trial of its antibody treatment for Covid-19